scholarly journals Publishing addiction: a behavioural disorder with specific characteristics

Author(s):  
A.Y. Finlay
Keyword(s):  
2021 ◽  
Vol 89 (06) ◽  
pp. 273-274

2013 hatte die Internationale RBD Study Group (IRBDSG) ein Konsensusstatement zu klinischen Studien zur symptomatischen oder krankheitsmodifizierenden Therapie bei REM-Schlaf-Verhaltensstörung (REM sleep behavioural disorder, RBD) veröffentlicht. Aufgrund des wissenschaftlichen Fortschritts war es höchste Zeit, die aktuellen Erkenntnisse zur Therapie der RBD in eine Neuauflage einfließen zu lassen.


Author(s):  
Kalpana Raman

This chapter attempts to individually understand the concept of adolescence and ADHD before it combines to the understanding of the progression of ADHD as a neurodevelopmental and behavioural disorder moving through the lifespan in different formats/symptoms. This understanding would provide the clinicians and academicians clarity to follow the golden rule of ‘early diagnosis early intervention' by identifying the progressive nature in terms of genetic, biochemistry, psycho-social, and personality aspects maintaining the disorder. Finally, this chapter would also provide an overview about the possible interventions and treatment plans available and briefly discusses the recent issues and trends throughout the chapter.


2019 ◽  
Vol 217 (1) ◽  
pp. 377-382
Author(s):  
Archana Basu ◽  
Dóra Körmendiné Farkas ◽  
Tammy Jiang ◽  
Karestan C. Koenen ◽  
Timothy L. Lash ◽  
...  

BackgroundProspective population-based studies of psychiatric comorbidity following trauma and severe stress exposure in children are limited.AimsTo examine incident psychiatric comorbidity following stress disorder diagnoses in Danish school-aged children using Danish national healthcare system registries.MethodChildren (6–15 years of age) with a severe stress or adjustment disorder (ICD-10) between 1995 and 2011 (n = 11 292) were followed prospectively for an average of 5.8 years. Incident depressive, anxiety and behavioural disorder diagnoses were examined relative to an age- and gender-matched comparison cohort (n = 56 460) using Cox proportional hazards regression models. Effect modification by gender was examined through stratified analyses.ResultsAll severe stress and adjustment disorder diagnoses were associated with increased rates for all incident outcome disorders relative to the comparison cohort. For instance, adjustment disorders were associated with higher rates of incident depressive (rate ratio RR = 6.8; 95% CI 6.0–7.7), anxiety (RR = 5.3; 95% CI 4.5–6.4), and behavioural disorders (RR = 7.9; 95% CI 6.6–9.3). Similarly, PTSD was also associated with higher rates of depressive (RR = 7.4; 95% CI 4.2–13), anxiety (RR = 7.1; 95% CI 3.5–14) and behavioural disorder (RR = 4.9; 95% CI 2.3–11) diagnoses. There was no evidence of gender-related differences.ConclusionsStress disorders varying in symptom constellation and severity are associated with a range of incident psychiatric disorders in children. Transdiagnostic assessments within a longitudinal framework are needed to characterise the course of post-trauma or severe stressor psychopathology.


2020 ◽  
pp. 1-10
Author(s):  
Richard Stevenson ◽  
Derek K. Tracy

SUMMARY The phenomenon of acute behavioural disturbance (ABD) (also known as acute behavioural disorder or excited delirium) is an underrecognised and potentially life-threatening syndrome, and an emergency in psychiatric settings. Causes are discussed and the pathophysiology explained. The challenges faced by practitioners are highlighted, including how ‘standard’ control and restraint can exacerbate symptoms. Initial treatment strategies are suggested.


1988 ◽  
Vol 152 (5) ◽  
pp. 683-686 ◽  
Author(s):  
M. Ghaziuddin

A retrospective study of 65 consecutive referrals for behavioural disorder of mentally handicapped patients living in the community revealed that 31 of these were associated with life events sustained in the 12 months prior to the referral. These patients were usually mildly handicapped, while those who presented with behaviour disorder without a history of recent life events were usually more severely retarded. The differences between the two groups are discussed and the need for further research emphasised.


2020 ◽  
Vol 91 (7) ◽  
pp. 740-749 ◽  
Author(s):  
Aleksandar Videnovic ◽  
Yo-El S Ju ◽  
Isabelle Arnulf ◽  
Valérie Cochen-De Cock ◽  
Birgit Högl ◽  
...  

The rapid eye movement sleep behavioural disorder (RBD) population is an ideal study population for testing disease-modifying treatments for synucleinopathies, since RBD represents an early prodromal stage of synucleinopathy when neuropathology may be more responsive to treatment. While clonazepam and melatonin are most commonly used as symptomatic treatments for RBD, clinical trials of symptomatic treatments are also needed to identify evidence-based treatments. A comprehensive framework for both disease-modifying and symptomatic treatment trials in RBD is described, including potential treatments in the pipeline, cost-effective participant recruitment and selection, study design, outcomes and dissemination of results. For disease-modifying treatment clinical trials, the recommended primary outcome is phenoconversion to an overt synucleinopathy, and stratification features should be used to select a study population at high risk of phenoconversion, to enable more rapid clinical trials. For symptomatic treatment clinical trials, objective polysomnogram-based measurement of RBD-related movements and vocalisations should be the primary outcome measure, rather than subjective scales or diaries. Mobile technology to enable objective measurement of RBD episodes in the ambulatory setting, and advances in imaging, biofluid, tissue, and neurophysiological biomarkers of synucleinopathies, will enable more efficient clinical trials but are still in development. Increasing awareness of RBD among the general public and medical community coupled with timely diagnosis of these diseases will facilitate progress in the development of therapeutics for RBD and associated neurodegenerative disorders.


2014 ◽  
Vol 87 (3) ◽  
pp. 293-295 ◽  
Author(s):  
M. Córdoba ◽  
S. Rodriguez ◽  
D. González Morón ◽  
N. Medina ◽  
M.A. Kauffman

Sign in / Sign up

Export Citation Format

Share Document